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Abstract: 
 
Background: Although soluble mediators released by basophils in tissue sites contribute to the 
chronic injury that occurs in hypersensitivity diseases, only limited information is available 
about how circulating basophils are recruited to tissues. In particular, the interaction of basophils 
with endothelium under conditions that mimic physiologic flow has not been explored. 
Objective: We sought to identify adhesion molecules regulating the attachment of human 
basophils to IL-4-activated human umbilical vein endothelial cells (HUVECs) under flow 
conditions. Methods: A parallel-plate flow chamber and blocking mAbs were used to define 
the adhesion molecules involved in the interactions of peripheral blood basophils (PBBs) and 
cord blood-derived basophils (CBDBs) with IL-4-activated HUVECs and with Chinese 
hamster ovary (CHO) cell transfectants expressing specific adhesion molecules. A fluorescent 
ligand specific for very late antigen 4 (VLA-4) was used to directly examine the VLA-4 affinity 
state of basophils. Results: Flowing PBBs and CBDBs attached to activated HUVECs and to 
CHO cells expressing P- or E-selectin. However, only CBDBs attached to vascular cell adhesion 
molecule 1 (VCAM-1)-transfected CHO cells under flow conditions. The attachment of CBDBs 
to CHO cells was blocked by mAbs directed against E-selectin, P-selectin, and VCAM-1, 
whereas attachment of PBBs was blocked by E-selectin and P-selectin mAbs. Activating VLA-4 
with Mn2+ on PBBs resulted in adhesion to the VCAM-1-transfected CHO cells, indicating that 
VLA-4 activity on PBBs can be regulated, at least in part, through affinity changes. The Mn2+-
induced upregulation of basophil VLA-4 affinity was demonstrated directly by using a 
fluorescent ligand for VLA-4 and flow cytometry. Conclusions: The interaction of human 
CBDBs and PBBs with endothelium under flow conditions is mediated in part by both P- and E-
selectin. VLA-4 additionally contributes to the adhesion of flowing CBDBs. However, the 
affinity of VLA-4 is too low to support the adhesion under flow conditions of unstimulated 
PBBs. 
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Abbreviations 
CBDB: Coed blood-derived basophil 
CHO: Chinese hamster ovary 
HUVEC: Human umbilical vein endothelial cell 
PBB: Peripheral blood basophil 
PSGL-1: P-selectin glycoprotein logand 1 
VCAM-1: Vascular cell adhesion molecule 1 
VLA-4: Very late antigen 4 
 
Leukocytes interact with endothelium and extravasate into tissue through a cascade of molecular 
events that include (1) attachment and rolling on activated vascular endothelium, (2) activation 
by chemokines or other chemoattractants, and (3) firm arrest and transmigration through 
endothelium.1, 2, 3, 4 Monocytes, lymphocytes, neutrophils, and eosinophils each use a different 
combination of selectins and integrins to perform these sequential adhesion events. E- and P-
selectin are typically expressed on endothelium, whereas L-selectin and the α4β1 integrin very 
late antigen 4 (VLA-4) are typically expressed on leukocytes.3, 4 Tetrasaccharide moieties on 
leukocyte glycoproteins (eg, P-selectin glycoprotein ligand 1 [PSGL-1] and cutaneous leukocyte 
antigen) might serve as ligands for endothelial cell selectins.5 VLA-4 binds to vascular cell 
adhesion molecule 1 (VCAM-1), the expression of which might be induced on endothelium in 
response to specific cytokines.3 After rolling, arrest, and firm adhesion, subsequent 
transmigration depends on β1 or β2 integrins.1, 2, 3, 4, 5 
 
Allergic reactions in the skin and airways are often characterized by the infiltration of peripheral 
blood basophils (PBBs) during the chronic inflammation phase (the late phase), which occurs 
between 4 and 48 hours after allergen exposure.6 Previous static assays have implicated E-
selectin, P-selectin, and VLA-4 in the interaction of basophils with endothelium. However, the 
adhesive receptors that allow basophils to attach and roll under physiologic flow conditions have 
not been defined, in part because the parallel-plate flow chamber used commonly to make these 
measurements requires higher cell numbers than can be reasonably obtained from peripheral 
blood. 
 
We have now produced a miniaturized parallel-plate flow chamber7 that makes adhesion 
analyses with flowing PBBs feasible. In addition, techniques have been developed for 
differentiating basophils from umbilical cord blood; immunophenotyping data revealed a 
repertoire of adhesion receptors on the surface of these cord blood-derived basophils (CBDBs) 
that was very similar to that of PBBs.8 In the studies presented here, we use the well-defined 
flow field that exists in a parallel-plate flow chamber to determine which adhesion receptors 
mediate the attachment of PBBs and CBDBs to endothelium activated with IL-4, a key cytokine 
in allergic disease. 
 
Methods 
 
Reagents and mAbs 
 
Anti-FcϵRI-α subunit mAb 22E7 (IgG1)9 was a gift from Dr J. Kochan (Hoffman-La Roche, 
Nutley, NJ). Neutralizing mAbs directed against human E-selectin (IgG1, 7A9) and P-selectin 
(IgG1, WAPS12.2) were purified from hybridoma lines (ATCC, Rockville, Md), as described 
previously.10 Blocking mAbs against VCAM-1 (IgG1, 4B9) were a gift of Dr Tim Carlos 
(University of Pittsburgh, Pittsburgh, Pa). Recombinant IL-4 was obtained from Gibco 
(Gaithersburg, Md). Antibodies to PSGL-1 (IgG1, PL1) were purchased from Ancell (Bayport, 
Mich). Chinese hamster ovary (CHO) cells expressing human E-selectin (a gift of Dr M. 
Lawrence, Charlottesville, Va), P-selectin (a gift of Dr R. McEver, Oklahoma City, Okla), and 
VCAM-1 (a gift of D Leavesley, Adelaide, Australia) were maintained as described previously.11 
Human umbilical vein endothelial cells (HUVECs) were a gift from Robert Hoover (Vanderbilt 
University, Nashville, Tenn). The VLA-4-specific peptide (LDV peptide)12, 13 4-(N ́-2-
methylphenyl)ureido-YLDVPAAK-OH and its FITC-conjugated analog were synthesized at 
Commonwealth Biotechnologies, Inc (Richmond, Va) and prepared as previously described.13 
All reagents used were of the highest grade commercially available to avoid endotoxin 
contamination. 
 
Cells 
 
Venous blood (100-300 mL) was collected from normal, healthy, and nonmedicated donors who 
had given informed consent, as approved by the Human Studies Committee at the University of 
New Mexico. EDTA (0.01% vol/vol) was added as an anticoagulant. None of the donors were 
atopic on the basis of history. Basophils were partially purified by means of Percoll gradient 
centrifugation and negative selection or extensively purified by means of negative selection, as 
previously described.14, 15, 16 Cytocentrifuge preparations were prepared and stained with Wright-
Giemsa stain to obtain percentages of basophils (>95%). Suspension cultures of CBDBs were 
prepared by culturing IL-3-pulsed umbilical cord blood for 21 to 28 days, as described 
previously.8 
 
Basophil interaction with endothelium or CHO cell transfectants in a parallel-plate flow chamber 
 
Physiologic flow conditions (ranging from 1-4 dynes/cm2 in postcapillary venules) were 
reproduced in vitro by using a parallel-plate flow chamber that produces a well-defined laminar 
flow over confluent HUVEC monolayers grown on coverslips (GlycoTech, Rockville, Md). Our 
chamber was miniaturized to handle small volumes.7 In some experiments the HUVECs were 
incubated in media with or without IL-4 (50 ng/mL) for 24 hours, treated with saturating levels 
(20 μg/mL) of mAbs for 15 minutes at 37°C, or both before being placed in the chamber.11 A 
syringe pump (Harvard Apparatus, Natick, Mass) was used to perfuse suspensions of basophils 
(1 × 106/mL in RPMI and 10% FBS) through the chamber at a defined flow. All experiments 
were performed with HUVECs passed fewer than 5 times. Statistical analysis was performed 
with Graphpad Prism software (San Diego, Calif). Data sets were tested for significant 
differences by using the paired t test. A P value of less than .05 was considered to be statistically 
significant. 
 
The entire time period of leukocyte perfusion was videotaped under phase-contrast microscopy 
(Olympus, NY). All experiments were recorded with a Vicon VC240 CCD video camera and 
Toshiba KV-7168 recorder (ADI, Albuquerque, NM). The total number of attached cells (rolling 
and arrested) was determined from the videotape at 5 minutes by means of analysis of 8 to 10 
random fields (20× phase contrast objective). Rolling and arrested cells were easily visualized 
because they traveled more slowly than free-flowing cells. After experiments, high shear stress 
(>30 dynes/cm2) was applied to wash off attached basophils, and their identity as basophils was 
confirmed with Wright-Giemsa stain, as described previously.16 
 
Measurement of VLA-4 receptor affinity 
 
Equilibrium and kinetic analyses of FITC-labeled LDV peptide binding were performed as 
described with human leukocytes, including PBBs.13 For equilibrium-binding studies, PBBs 
were treated with various concentrations (0.3, 0.6, 1.5, 3.0, and 6.0 nmol/L) of the FITC-labeled 
LDV peptide for 15 minutes at 37°C (a time point previously shown adequate to reach 
equilibrium) in the presence or absence of MnCl2 . Nonspecific binding was determined by 
competing FITC peptide with a 500-fold excess of unlabeled peptide. Analysis was performed by 
means of FACs analysis, and 10,000 events were acquired. The resulting data were converted to 
mean channel fluorescence over time with Tru-Rate software as developed by Seamer and 
Sklar.17 To examine the dissociation rate constants (Koff) of the peptide from VLA-4, cells were 
preincubated with 6 to 15 nmol/L fluorescent peptide for 10 minutes at 37°C and then treated 
with 500-fold excess unlabeled peptide, and the dissociation of the fluorescent peptide was 
followed in a flow cytometer for up to 1000 seconds. Samples were analyzed for 30 to 120 
seconds to establish a baseline, the stimulus (Mn2+) was added, and FACS acquisition was 
immediately re-established. The resulting data were converted to mean channel fluorescence 
over time as above.17 Affinity constants (Kd) were determined as previously described.13 Data 
were analyzed by using the Student 2-sample t test to calculate statistical significance between 
different treatments versus control treatment. A P value of .05 or less was considered significant. 
Curve fits and statistics related to LDV peptide binding were performed with GraphPad Prism 
software. 
 
Results 
 
CBDBs and PBBs attach to activated endothelium under physiologic flow conditions 
 
The shear curves in Fig 1 compare the ability of CBDBs and PBBs to interact with resting and 
IL-4-stimulated HUVEC monolayers over a range of shear stresses (0-10 dynes/cm2) that 
recapitulated flow conditions in postcapillary venules. 
 
 
Fig. 1. Attachment of CBDBs and PBBs to endothelium under flow conditions. CBDBs (open symbols) or 
PBBs (filled symbols) were perfused over IL-4-activated (triangles) or unactivated (squares) endothelium by using a 
range of shear stresses. The number of cells that attached was determined from videotaped records. Data for 2.5 to 
10 dynes is not shown because no attachment occurred. The data represent mean ± SD values from 3 separate 
experiments and donors. *Indicates statistical significance, P = .03. 
 
IL-4 was selected as the stimulus because it is a well-documented allergic inflammatory cytokine 
that activates endothelium.18, 19 Twenty-four hours of IL-4 incubation was selected because it is 
consistent with the time of basophil emigration into tissue during the late phase of allergic 
reactions in vivo.20 CBDBs and PBBs did not interact significantly with unstimulated HUVECs. 
IL-4 stimulation increased the accumulation of CBDBs and PBBs with all flow rates examined. 
The number of CBDBs attaching at 1.5 dynes/cm2 was significantly higher compared with the 
number of PBBs. However, considerably less or no attachment occurred at higher shear stresses. 
Therefore all subsequent studies were carried out at 1.5 dynes/cm2. 
 
VLA-4 mediates initial attachment of CBDBs, but not PBBs, under flow conditions 
 
The mechanisms that mediate initial attachment of CBDBs and PBBs to IL-4-stimulated 
HUVECs were examined in mAb blocking experiments. As seen in Fig 2, A , mAbs to E-
selectin, P-selectin, and VCAM-1 all inhibited binding of CBDBs to IL-4-stimulated HUVEC 
monolayers under flow conditions. 
 
Individual antibodies reduced adhesion by 41%, 46%, and 57%, respectively. When a 
combination of any 2 antibodies was used, complete inhibition was seen with less than 2% cell 
attachment. Thus CBDBs appear to use a combination of E-selectin, P-selectin, or VLA-4 for 
attachment to IL-4-stimulated HUVECs. 
 
Monoclonal antibodies to P-selectin also significantly inhibited (71%) PBB binding to IL-4-
stimulated HUVECs. The contribution of E-selectin became apparent when mAbs against E- and 
P-selectin were used together, showing greater than 99% inhibition. In contrast, anti-VCAM-1 
mAbs did not significantly inhibit PBB attachment unless added with anti-P-selectin mAbs (Fig 
2, B ). Addition of anti-VCAM-1 and E-selectin mAbs did not decrease basophil attachment. 
These results imply that the E- and P-selectins, but not VLA/VCAM-1 interactions, mediate 
attachment of unstimulated PBBs to IL-4-activated endothelium under flow conditions. 
 
 
Fig. 2. Monoclonal antibody inhibition of CBDB and PBB attachment to activated endothelium under physiologic 
flow conditions. Confluent IL-4-stimulated HUVEC monolayers were incubated with mAbs at saturating 
concentrations. CBDBs (A) and PBBs (B) were perfused across the monolayers at 1.5 dynes/cm2. MOPC was added 
as a positive control. The number of cells that accumulated was determined from videotaped records. The data 
represent mean ± SD values from 3 separate experiments and donors. *P < .05. 
 
CBDBs, but not PBBs, bind to VCAM-1-transfected CHO monolayers 
 
The experiments in Fig 3 compare the attachment of CBDBs and PBBs with CHO cells 
transfected with human E-selectin (CHO-E), P-selectin (CHO-P), or VCAM-1 (CHO-V) under 
flow conditions. 
 
 
Fig. 3. Attachment of CBDBs and PBBs on CHO monolayers expressing human P-selectin, E-selectin, and VCAM-
1. Confluent CHO cell monolayers were incubated with mAbs at saturating concentrations. CBDBs (left) and 
PBBs (right) were perfused across the monolayers at 1.5 dynes/cm2. The number of cells that accumulated was 
determined from videotaped records. The data represent mean ± SD values from 3 separate experiments and donors. 
*P < .05. 
 
As seen in Fig 3 (left panels), CBDBs attached to CHO-E, CHO-P, and CHO-V monolayers at 
1.5 dynes/cm2, and the addition of mAbs to E- and P-selectins and VCAM-1 inhibited this 
attachment by approximately 80%, 83%, and 99%, respectively. PBBs also attached to CHO-P 
and CHO-E monolayers, and blocking mAbs to P- or E-selectin reduced this adhesion by 87% 
and 99%, respectively (Fig 3, right panels). PBBs did not attach to the CHO-V monolayer. 
 
It is well known that the affinity of VLA-4 for ligand can be upregulated both by signaling 
molecules that interact with VLA-4 cytoplasmic tail domains and by antibodies and cations, 
particularly Mn2+, that interact with VLA-4 extracellular domain.21, 22, 23, 24, 25, 26 As shown in 
Table I, PBBs showed a significant increase in attachment to CHO-V cells under flow conditions 
after incubation with Mn2+. 
 
Table I. Summary of affinity and off-rate constants on PBBs and CBDBs 
 Kd (nmol/L)* Koff (10−4/s−1)† No. of cells attaching to CHO-V 
PBBs (no stimulation) 13 (4) 600 (25) 12 (5) 
PBBs (Mn2+ stimulation) 0.2 (0.1) 25 (5) 57 (7) 
CBDBs (no stimulation) NA 33 (17) 52 (4) 
NA, Not applicable (see text for technical details). 
*Equilibrium-binding experiments were conducted with VLA-4-specific peptide by using PBBs with or without 
Mn2+ stimulation. The Kd (affinity constant) of VLA-4 on resting PBBs was determined as previously described.13 
The Koff (association constant) was determined as described in the “Methods” section. In parallel, flow experiments 
were conducted to monitor PBB adherence to CHO-V. †Mean (SD) values are shown. 
 
Enhanced VLA-4 affinity measured with a VLA-4-binding peptide 
 
Recently, a VLA-4-binding peptide derived from the LDV-binding sequence of VCAM-1 
specific for VLA-4 was developed.26 In its fluorescence-labeled form, this peptide might be used 
to detect the affinity state of VLA-4 on cells by means of flow cytometry.13 We used this peptide 
to measure VLA-4 affinity in resting and Mn2+-stimulated PBBs. There was no detectable 
binding of fluorescent LDV peptide to unstimulated PBBs. In contrast, equilibrium-binding 
studies demonstrated that the Kd of VLA-4 for peptide in the presence of Mn2+ was 
approximately 0.2 nmol/L, a value similar to that detected on other leukocytes after Mn2+ 
stimulation.12, 13, 24, 25, 26 
 
Measurements of VLA-4 affinity on resting CBDBs were complicated by the high level of 
autofluorescence in the cultured cells, and the addition of Mn2+ to CBDBs caused cell death (data 
not shown). We therefore compared the VLA-4 activation state on CBDBs and PBBs by using 
dissociation rate constants. Unstimulated CBDBs and unstimulated and Mn2+-stimulated PBBs 
were incubated with 500-fold excess of nonlabeled LDV peptide to induce dissociation, as 
described previously.13 Using this protocol, we determined that VLA-4 on activated CBDBs was 
in a very similar affinity state as VLA-4 on resting CBDBs (Table I). On the basis of the general 
principle that the lower the Koff the higher the affinity constant, VLA-4 on CBDBs is in a higher 
affinity state than on nonstimulated PBBs. 
 
Immunophenotyping studies28, 29, 30, 31 confirmed that IL-4 stimulation of HUVECs induced 
expression of VCAM-1, P-selectin, and E-selectin on IL-4-stimulated HUVECs after 24 hours 
(data not shown). Also as expected,6, 8, 32, 33 both CBDBs and PBBs express the integrins α4β1 
(VLA-4) and PSGL-1 and the E-selectin ligand cutaneous leukocyte antigen. 
 
Discussion 
 
In this study the attachment of human basophils to IL-4-stimulated endothelial cells under flow 
conditions was studied by using a miniaturized parallel-plate flow chamber. Wall shear stresses 
were selected that approximated those in postcapillary venules, where basophil extravasation 
takes place.34 We found that human PBBs and CBDBs interact with IL-4-stimulated endothelial 
cells at levels of wall shear stress of up to 1.5 dynes/cm2. The inverse relationship between shear 
stress and adherence, as well as the magnitude of adhesive interactions, is in agreement with the 
findings of previous investigators examining in vitro flow models with human monocytes, 
lymphocytes, eosinophils, and neutrophils.11, 35, 36, 37, 38, 39 Experiments with blocking antibodies 
established that both PBBs and CBDBs use E- and P-selectin for attachment to endothelium. 
CBDBs also used VLA-4 to mediate adhesion to endothelium. However, unstimulated PBBs do 
not use VLA-4 to attach. 
 
VLA-4 has been shown previously to exist in multiple activation states.26, 40 In particular, 
constitutive VLA-4 avidity has been described on precurser leukocytes and early lymphocytes, 
whereas more differentiated cells have regulated VLA-4 avidity.11, 15, 41, 42, 43, 44 Thus the 
differences we see in the CBDBs and PBBs might reflect a less differentiated state of CBDBs 
compared with PBBs. Differences in maturation levels between CBDBs and PBBs were 
previously suggested by the observation that only a subset of CBDBs react with the PBB-specific 
mAb 2D7.8, 16 The switch of VLA-4 affinity on PBBs to a higher-affinity state induced by Mn2+, 
previously shown to induce higher VLA-4 affinity confirmations,45 corresponds with acquisition 
of PBB adherence to CHO-V under flow conditions. These findings are consistent with recent 
results with a conjugate-forming assay, in which it was shown that PBB VLA-4 switches from a 
lower- to a higher-avidity state after both Mn2+ and antigen challenge.46 
 
Earlier studies of basophil attachment under static conditions implicated E- and P-selectin-
mediated interactions in basophil adhesion to endothelium.19, 32, 33 Extending these studies, our 
results with CHO transfectants confirm a role for E- and P-selectin in the attachment of CBDBs 
and PBBs to endothelium under flow conditions. Previous studies also implicated VLA-4 in the 
static adhesion of unstimulated PBBs to endothelium and endothelial models.31, 32 In contrast, 
PBBs show no VLA-4-mediated adhesion to either HUVECs or CHO-V cells under the flow 
conditions used in our study. Thus static adhesion assays might provide results that are 
misleading when extrapolated to a physiologic context. 
 
It is becoming evident that basophils play a substantial role in chronic allergic inflammation, 
including asthma, and, by extension, that understanding how basophils migrate into tissues might 
have important therapeutic implications. The use of flow conditions to examine basophil 
adhesion to endothelium is an important step toward the development and testing of specific 
antagonists of this process. 
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